Document is current
Any future updates will be listed below
-
Authors
Fueger, Barbara J.
Tollens, Fabian
Kaiser, Clemens G. N.
Helbich, Thomas H.
Pötsch, Nina
Clauser, Paola
Baltzer, Pascal A. T. https://orcid.org/0000-0002-3755-5398
-
Funding
Funding for this research was provided by:
Wiener Wirtschafts und Technologie Fonds
- License Information
-
More Information
Article History
Received: 27 November 2024
Accepted: 6 May 2025
First Online: 12 June 2025
Declarations
:
: Our analysis included only published information, and no patients were examined by us. Therefore, no IRB approval nor patient consent was necessary.
: Our analysis included only published information, and no patients were examined by us. Therefore, no IRB approval nor patient consent was necessary.
: T.H.H.: Research support in part by Novemed, Austria, and BD, Austria. P.C. is the Editor-in-Chief of Insights into Imaging, and as such did not participate in the selection or review processes for this article.
: This study employed a decision-analytic model and Markov simulation to evaluate the cost-effectiveness of supplemental contrast-enhanced breast MRI compared to stereotactic VABB in women with BI-RADS 4 mammographic microcalcifications.
